Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Graft-In is an Israeli medical technology company specializing in the development and manufacture of advanced biomaterials for bone grafting and tissue regeneration. The company's primary focus is on dental and orthopedic applications, providing a range of synthetic and biological bone substitutes, collagen membranes, and wound dressing solutions. Graft-In's products are designed to facilitate bone growth and structural support in procedures such as sinus lifts, ridge augmentations, and periodontal defects. The company operates with a focus on high-quality manufacturing and clinical efficacy to serve the global dental implantology and regenerative medicine markets. Graft-In is led by experienced medical device entrepreneurs and maintains a strong presence in the international dental community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GraftIn.